Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Journal of Drugs in Dermatology : JDD
|
February 4, 2021
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey
Melinda Gooderham, Kim Papp, Lorne Albrecht, et al.
Journal of the American Academy of Dermatology
|
August 3, 2019
Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm<sup>2</sup> on the chest: A phase 3 randomized controlled trial
C William Hanke, Lorne Albrecht, Torsten Skov, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
Gurbir Dhadwal, Lorne Albrecht, Robert Gniadecki, et al.
Journal of Cutaneous Medicine and Surgery
|
December 29, 2011
Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations
Lorne Albrecht, Marc Bourcier, John Ashkenas, et al.
Dermatology and Therapy
|
December 23, 2022
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
Melinda Gooderham, Kim A Papp, Charles Lynde, et al.
Journal of the American Academy of Dermatology
|
August 3, 2021
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
Linda Stein Gold, Kim Papp, David Pariser, et al.
BMC Dermatology
|
June 23, 2019
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America
Kim A Papp, Melinda Gooderham, Jennifer Beecker, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Treatment Options
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Journal of Drugs in Dermatology : JDD
|
February 4, 2021
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey
Melinda Gooderham, Kim Papp, Lorne Albrecht, et al.
Journal of the American Academy of Dermatology
|
August 3, 2019
Efficacy and safety of ingenol mebutate gel in field treatment of actinic keratosis on full face, balding scalp, or approximately 250 cm<sup>2</sup> on the chest: A phase 3 randomized controlled trial
C William Hanke, Lorne Albrecht, Torsten Skov, et al.
Journal of Cutaneous Medicine and Surgery
|
November 16, 2018
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section IV: Treatment Options for the Management of Atopic Dermatitis
Gurbir Dhadwal, Lorne Albrecht, Robert Gniadecki, et al.
Journal of Cutaneous Medicine and Surgery
|
December 29, 2011
Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations
Lorne Albrecht, Marc Bourcier, John Ashkenas, et al.
Dermatology and Therapy
|
December 23, 2022
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry
Melinda Gooderham, Kim A Papp, Charles Lynde, et al.
Journal of the American Academy of Dermatology
|
August 3, 2021
Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: Results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial
Linda Stein Gold, Kim Papp, David Pariser, et al.
BMC Dermatology
|
June 23, 2019
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America
Kim A Papp, Melinda Gooderham, Jennifer Beecker, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Presentation, Diagnosis, and Special Populations
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Epidemiology, Burden of Disease, and Pathophysiology
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Journal of Cutaneous Medicine and Surgery
|
September 18, 2025
Current Understanding of Seborrheic Dermatitis: Treatment Options
Irina Turchin, Lorne Albrecht, Sameh Hanna, et al.
Page
of 2